Lupeng Pharmaceutical
PrivateLast Round
Series B
Sep 1, 2025
Est. Valuation
$311M
Total Funding Raised
$160.2M
Company Overview
Lupeng Pharmaceutical is a clinical-stage biopharmaceutical company that discovers and develops innovative small molecule drugs for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lupeng Pharmaceutical Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Lupeng Pharmaceutical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 1, 2025 | ||||
| Follow-on Offering | Nov 16, 2022 | ||||
| VC Round | Jul 27, 2021 | ||||
| Series A Extension | Jun 23, 2020 | ||||
| Series A | Jan 1, 2019 | ||||
Seed | Jun 27, 2018 |
Lupeng Pharmaceutical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Series A |
| Temasek | Series B, VC Round, Follow-on Offering |
| Lake Bleu Capital | VC Round, Follow-on Offering |
| Kaitai Capital | Seed, Series A Extension, Series B, Follow-on Offering |
| TF Capital | Series B |
| OrbiMed | Series B |
| Lilly Asia Ventures | VC Round, Series B, Follow-on Offering, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2021
$35M round led by Temasek
Lupeng Pharmaceutical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lupeng Pharmaceutical's valuation, stock price, and market status.